How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Amazon Q Developer is a useful AI-powered coding assistant with chat, CLI, Model Context Protocol and agent support, and AWS ...
Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
The following slide deck was published by Recursion Pharmaceuticals, Inc. in conjunction with this event.
This is the next line of Sentry JavaScript SDKs, comprised in the @sentry/ namespace. It will provide a more convenient interface and improved consistency between various JavaScript environments. We ...
@traversable/schema is a general purpose schema rewriting tool. At the time of writing, it is home to the fastest deep equal and fastest deep clone functions in the JavaScript ecosystem. A schema is a ...
Get the latest news and real-time alerts from Recursion Pharmaceuticals, Inc. (RXRX) stock at Seeking Alpha.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback